Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronised oral progesterone

References

• Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–337.
   PubMed Web of Science ®Google Scholar
• Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. The Lancet 2003;362:419–427.
   PubMed Web of Science ®Google Scholar
• Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, et al Women's Health Initiative. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004;81:1498–1501.
   PubMed Web of Science ®Google Scholar
• Ylikorkala O.HRT as secondary prevention of cardiovascular disease. Maturitas 2004;47:315–318.
   PubMed Web of Science ®Google Scholar
• Beral V, Bull D, Green J, Reeves G; Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. The Lancet 2007;369:1703–1710.
   PubMed Web of Science ®Google Scholar
• Pérez-Lopez FR, Chedraui P, Gilbert JJ, Pérez-Roncero G.Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009;64:1171–1186.
   Google Scholar
• Scarabin PY, Oger E, Plu-Bureau G; EStrogen and THromboEmbolism Risk Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003;362:428–432.
   PubMed Web of Science ®Google Scholar
• Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, et al Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115:840–845.
   PubMed Web of Science ®Google Scholar
• L'Hermite M, Simoncini T, Fuller S, Genazzani AR.Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 2008;60:185–201.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR.Menopause hormone replacement therapy: controversial, accuracy and outlook issues. Med Clin (Barc) 2003;120:148–155.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Cuadros-López JL, Fernández-Alonso AM, Cuadros-Celorrio AM, Sabatel-López RM, Chedraui P.Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens. Gynecol Endocrinol, in press.
   Google Scholar
• Burger HG, Hale GE, Dennerstein L, Robertson DM.Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603–612.
   PubMed Web of Science ®Google Scholar
• Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ.Testing ovarian reserve to predict age at menopause. Maturitas 2009;63:280–291.
   PubMed Web of Science ®Google Scholar
• Sowers MF, Zheng H, McConnell D, Nan B, Karvonen-Gutierrez CA, Randolph JF Jr.Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. Hum Reprod 2009;24:2276–2285.
   PubMed Web of Science ®Google Scholar
• Ali I, James T, Meston N, Wojnarowska F, Shine B.Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female. Clin Chem Lab Med 2009;47:202–207.
   PubMed Web of Science ®Google Scholar
• Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ.Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555–1561.
   PubMed Web of Science ®Google Scholar
• Waaseth M, Bakken K, Dumeaux V, Olsen KS, Rylander C, Figenschau Y, Lund E.Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis. BMC Womens Health 2008;8:1.
   PubMedGoogle Scholar
• Schilling C, Gallicchio L, Miller SR, Langenberg P, Zacur H, Flaws JA.Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women. Climacteric 2007;10:27–37.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A.Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45–53.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR.Hormone replacement therapy. The Menopause, Madrid:Temas de Hoy 1992;227–243.
   Google Scholar
• Tanaka H, Clevenger CM, Jones PP, Seals DR, DeSouza CA.Influence of body fatness on the coronary risk profile of physically active postmenopausal women. Metabolism 1998;47:1112–1120.
   PubMed Web of Science ®Google Scholar
• Crawford SL, Casey VA, Avis NE, McKinlay SM.A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 2000;7:96–104.
   PubMed Web of Science ®Google Scholar
• Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC.Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med 2000;160:3315–3325.
   PubMed Web of Science ®Google Scholar
• Demir B, Ozturkoglu E, Solaroglu A, Baskan B, Kandemir O, Karabulut E, Haberal A.The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women. Gynecol Endocrinol 2008;24:347–353.
   PubMed Web of Science ®Google Scholar
• Stevenson JC.Type and route of estrogen administration. Climacteric 2009;12(Suppl 1):86–90.
   PubMedGoogle Scholar
• Pérez-López FR, Larrad-Mur L, Carlson A, Chedraui P, Taylor HS.Gender differences in cardiovascular disease: Hormonal and biochemical influences. Reprod Sci, in press.
   Google Scholar
• Fernandes CE, Pompei LM, Machado RB, Ferreira JA, Melo NR, Peixoto S.Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. Maturitas 2008;59:249–258.
   PubMed Web of Science ®Google Scholar
• Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, Lanzone A.Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 1999;140:215–223.
   PubMed Web of Science ®Google Scholar
• Godsland IF, Manassiev NA, Felton CV, Proudler AJ, Crook D, Whitehead MI, Stevenson JC.Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women. Clin Endocrinol (Oxf) 2004;60:541–549.
   PubMed Web of Science ®Google Scholar
• Schindler TH, Campisi R, Dorsey D, Prior JO, Olschewski M, Sayre J, Schelbert HR.Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. Eur Heart J 2009;30:978–986.
   PubMed Web of Science ®Google Scholar
• Huber JC, Campagnoli C, Druckmann R, Ebert C, Pasqualini JR, Ruby J, Schweppe KW, Schindler AE, Thijssen JH.Recommendations for estrogen and progestin replacement in the climacteric and postmenopause. Eur Progestin Club, Maturitas 1999;33:197–209.
   PubMed Web of Science ®Google Scholar
• Stojanovic ND, Kwong P, Byrne DJ, Arnold A, Jagroop IA, Nair D, Press M, Hurel S, Mikhailidis DP, Prelevic GM.The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study. Angiology 2003;54:391–399.
   PubMed Web of Science ®Google Scholar
• Fenkci S, Fenkci V, Yilmazer M, Serteser M, Koken T.Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension. Hum Reprod 2003;18:866–870.
   PubMed Web of Science ®Google Scholar
• Chu MC, Cosper P, Nakhuda GS, Lobo RA.A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 2006;86:1669–1675.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE.Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538–554.
   PubMed Web of Science ®Google Scholar
• Lobo RA.Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10–18.
   PubMed Web of Science ®Google Scholar
• Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Menopause 2006;13:643–650.
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM, Golden SH.The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009;94:4127–4135.
   PubMed Web of Science ®Google Scholar
• Akin F, Bastemir M, Alkiş E, Kaptanoglu B.SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Intern Med 2009;20:162–167.
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S.Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152–1163.
   PubMed Web of Science ®Google Scholar
• Koskova I, Petrasek R, Vondra K, Duskova M, Starka L.Metabolic profile and sex hormone binding globulin (SHBG) in different reproductive phases of Czech women and their relations to weight, body composition and fat distribution. Physiol Res 2009;58:393–402.
   PubMed Web of Science ®Google Scholar
• Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women. J Endocrinol Invest 1996;19:535–541.
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. Maturitas 2002;41:299–311.
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Miya Y, Sakamaki T, Kurabayashi M.Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy. Am J Hypertens 2005;18:1340–1346.
   PubMed Web of Science ®Google Scholar
• Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women. Geriatr Gerontol Int 2008;8:259–264.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB.Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066–3072.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr;International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Lera Orsatti F, Petri Nahas EA, Nahas-Neto J, Maesta N, Lera Orsatti C, De Luca Vespoli H, Traiman P.Association between anthropometric indicators of body fat and metabolic risk markers in post-menopausal women. Gynecol Endocrinol 2010;26:16–22.
   PubMed Web of Science ®Google Scholar
• Sare GM, Gray LJ, Bath PM.Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008;29:2031–2041.
   PubMed Web of Science ®Google Scholar
• Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. J Thromb Haemost 2006;4:1259–1265.
   PubMed Web of Science ®Google Scholar
• Lobo RA.Menopause and stroke and the effects of hormonal therapy. Climacteric 2007;10(Suppl 2):27–31.
   PubMed Web of Science ®Google Scholar
• Pollin IS, Kral BG, Shattuck T, Sadler MD, Boyle JR, McKillop L, Campbell C, Ashen MD, Nasir K, Redberg RF, et al High prevalence of cardiometabolic risk factors in women considered low risk by traditional risk assessment. J Womens Health (Larchmt) 2008;17:947–953.
   PubMed Web of Science ®Google Scholar
• Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, et al The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010;53:600–605.
   PubMed Web of Science ®Google Scholar
• Kissebah AH, Peiris AN.Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83–109.
   PubMed Web of Science ®Google Scholar
• Despres JP.Cardiovascular disease under the influence of excess visceral fat. Crit Path Cardiol 2007;6:51–59.
   PubMedGoogle Scholar